{"id":"https://openalex.org/W2064320461","doi":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","title":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow\u2010up study","display_name":"Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow\u2010up study","alternate_titles":[],"publication_year":1999,"publication_date":"1999-11-01","ids":{"openalex":"https://openalex.org/W2064320461","doi":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","mag":"2064320461","pmid":"https://pubmed.ncbi.nlm.nih.gov/10594479","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2014356"},"language":"en","primary_location":{"id":"doi:10.1046/j.1365-2125.1999.00070.x","doi":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2064320461"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2014356/","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5053151541","display_name":"Pitt O. Lim","orcid":"https://orcid.org/0000-0001-8821-3008","observed_orcids":["https://orcid.org/0000-0001-8821-3008"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I2802526638","display_name":"Ninewells Hospital","ror":"https://ror.org/039c6rk82","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831","https://openalex.org/I2802526638"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Lim","raw_affiliation_strings":["Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I2802526638"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105275288","display_name":"Jung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I2802526638","display_name":"Ninewells Hospital","ror":"https://ror.org/039c6rk82","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831","https://openalex.org/I2802526638"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jung","raw_affiliation_strings":["Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I2802526638"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5072989992","display_name":"Thomas MacLennan MacDonald","orcid":"https://orcid.org/0000-0001-5189-6669","observed_orcids":["https://orcid.org/0000-0001-5189-6669"]},"institutions":[{"id":"https://openalex.org/I177639307","display_name":"University of Dundee","ror":"https://ror.org/03h2bxq36","country_code":"GB","type":"education","lineage":["https://openalex.org/I177639307"]},{"id":"https://openalex.org/I2802526638","display_name":"Ninewells Hospital","ror":"https://ror.org/039c6rk82","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800860831","https://openalex.org/I2802526638"]}],"countries":["GB"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MacDonald","raw_affiliation_strings":["Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hypertension Research Centre, Department of Clinical Pharmacology and Therapeutics, and Department of Endocrinology and Diabetes, Ninewells Hospital and Medical School, University of Dundee, Dundee, UK","institution_ids":["https://openalex.org/I177639307","https://openalex.org/I2802526638"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":3.4352,"has_fulltext":false,"cited_by_count":159,"citation_normalized_percentile":{"value":0.92270037,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"48","issue":"5","first_page":"756","last_page":"760"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11839","display_name":"Hormonal Regulation and Hypertension","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10144","display_name":"Blood Pressure and Hypertension Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/aldosterone-to-renin-ratio","display_name":"aldosterone-renin ratio","score":0.8730000257492065},{"id":"https://openalex.org/keywords/spironolactone","display_name":"spironolactone","score":0.9300000071525574},{"id":"https://openalex.org/keywords/primary-aldosteronism","display_name":"primary aldosteronism","score":0.9929999709129333},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.9440000057220459},{"id":"https://openalex.org/keywords/antihypertensive-efficacy","display_name":"antihypertensive efficacy","score":0.8730000257492065},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.5899999737739563},{"id":"https://openalex.org/keywords/mineralocorticoid-receptor-antagonists","display_name":"mineralocorticoid receptor antagonists","score":0.8199999928474426},{"id":"https://openalex.org/keywords/antihypertensive-medication-reduction","display_name":"antihypertensive medication reduction","score":0.8240000009536743},{"id":"https://openalex.org/keywords/breast-tenderness","display_name":"breast tenderness","score":0.8450000286102295},{"id":"https://openalex.org/keywords/salt-loading-test","display_name":"salt loading test","score":0.5680000185966492},{"id":"https://openalex.org/keywords/fludrocortisone-suppression-test","display_name":"fludrocortisone suppression test","score":0.9959999918937683},{"id":"https://openalex.org/keywords/blood-pressure-reduction","display_name":"blood pressure reduction","score":0.6990000009536743}],"concepts":[{"id":"https://openalex.org/C2776379505","wikidata":"https://www.wikidata.org/wiki/Q422188","display_name":"Spironolactone","level":3,"score":0.9137700796127319},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.847221314907074},{"id":"https://openalex.org/C2780233176","wikidata":"https://www.wikidata.org/wiki/Q1939330","display_name":"Primary aldosteronism","level":3,"score":0.765988826751709},{"id":"https://openalex.org/C2778525890","wikidata":"https://www.wikidata.org/wiki/Q184564","display_name":"Aldosterone","level":2,"score":0.7374893426895142},{"id":"https://openalex.org/C2776899810","wikidata":"https://www.wikidata.org/wiki/Q2697578","display_name":"Fludrocortisone","level":3,"score":0.6917507648468018},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6294056177139282},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.5972243547439575},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5414003133773804},{"id":"https://openalex.org/C138976137","wikidata":"https://www.wikidata.org/wiki/Q7201790","display_name":"Plasma renin activity","level":4,"score":0.47852835059165955},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.4434260129928589},{"id":"https://openalex.org/C57900726","wikidata":"https://www.wikidata.org/wiki/Q492905","display_name":"Diastole","level":3,"score":0.43105459213256836},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4287177622318268},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.3929882049560547},{"id":"https://openalex.org/C198710026","wikidata":"https://www.wikidata.org/wiki/Q898218","display_name":"Renin\u2013angiotensin system","level":3,"score":0.303966224193573},{"id":"https://openalex.org/C2778709874","wikidata":"https://www.wikidata.org/wiki/Q190875","display_name":"Hydrocortisone","level":2,"score":0.1573338508605957}],"mesh":[{"descriptor_ui":"D000450","descriptor_name":"Aldosterone","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D000451","descriptor_name":"Mineralocorticoid Receptor Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000893","descriptor_name":"Anti-Inflammatory Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000959","descriptor_name":"Antihypertensive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005438","descriptor_name":"Fludrocortisone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005500","descriptor_name":"Follow-Up Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012083","descriptor_name":"Renin","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":true},{"descriptor_ui":"D013148","descriptor_name":"Spironolactone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1046/j.1365-2125.1999.00070.x","doi":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","is_oa":false,"landing_page_url":"https://doi.org/10.1046/j.1365-2125.1999.00070.x","pdf_url":null,"source":{"id":"https://openalex.org/S13842274","display_name":"British Journal of Clinical Pharmacology","issn_l":"0306-5251","issn":["0306-5251","1365-2125"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Clinical Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:2014356","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2014356/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},{"id":"pmid:10594479","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/10594479","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of clinical pharmacology","raw_type":"Clinical Trial"},{"id":"pmh:oai:discovery.dundee.ac.uk:openaire/b23bd646-fd31-40b5-8dfd-8b3ba3b6c172","doi":null,"is_oa":true,"landing_page_url":"https://discovery.dundee.ac.uk/en/publications/b23bd646-fd31-40b5-8dfd-8b3ba3b6c172","pdf_url":null,"source":{"id":"https://openalex.org/S4306400523","display_name":"Discovery Research Portal (University of Dundee)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177639307","host_organization_name":"University of Dundee","host_organization_lineage":["https://openalex.org/I177639307"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Lim, P O, Jung, R T & MacDonald, T M 1999, 'Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone : A prospective cohort follow-up study', British Journal of Clinical Pharmacology, vol. 48, no. 5, pp. 756-760. https://doi.org/10.1046/j.1365-2125.1999.00070.x","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:2014356","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2014356/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Clin Pharmacol","raw_type":"Text"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1603490609","https://openalex.org/W1964648021","https://openalex.org/W1974986453","https://openalex.org/W1984859539","https://openalex.org/W2007598116","https://openalex.org/W2017666632","https://openalex.org/W2025618817","https://openalex.org/W2086078813","https://openalex.org/W2146059439","https://openalex.org/W2164126102","https://openalex.org/W2431047620","https://openalex.org/W2950487652","https://openalex.org/W4229736087","https://openalex.org/W4231249271","https://openalex.org/W4246934698","https://openalex.org/W4252126843"],"related_works":["https://openalex.org/W2018629716","https://openalex.org/W2037061023","https://openalex.org/W2119642449","https://openalex.org/W2082897578","https://openalex.org/W2982161996","https://openalex.org/W2336401258","https://openalex.org/W2469396368","https://openalex.org/W2007001442","https://openalex.org/W7203688870","https://openalex.org/W2039613023"],"abstract_inverted_index":{"AIMS:":[0],"Aldosterone/renin":[1],"ratio":[2,301],"is":[3,12],"an":[4],"index":[5,31],"for":[6,18,97,125,250],"inappropriate":[7],"aldosterone":[8,57,80,309],"activity,":[9],"and":[10,84,94,174,181,215,228,271],"it":[11,313],"increasingly":[13],"being":[14],"used":[15,197],"to":[16,32,37,45,58,77,102,183,199],"screen":[17],"primary":[19,52,311],"aldosteronism":[20,53],"within":[21],"the":[22,35,41,135,187,191,248],"hypertensive":[23,49,69,290,323],"population.":[24],"It":[25],"may":[26],"also":[27],"be":[28,315],"a":[29,64,98,113,126,139,211,218,284,294,299],"good":[30],"help":[33],"predict":[34],"response":[36,44],"spironolactone.":[38],"To":[39],"assess":[40],"blood":[42,262],"pressure":[43,263],"oral":[46],"spironolactone":[47,93,180,200,234,245,318],"in":[48,289,319],"patients":[50,70,89,136,166,238,291,324],"with":[51,55,71,81,92,112,157,233,325,335],"identified":[54],"raised":[56,72,295,300,326],"renin":[59],"ratio.":[60,297],"METHODS:":[61],"We":[62,106],"conducted":[63],"prospective":[65],"cohort":[66],"study":[67],"of":[68,100,116,129,141,168,179,194,305,307,322],"aldosterone/renin":[73,296,327],"ratio,":[74],"who":[75,121,292],"failed":[76],"suppress":[78],"plasma":[79,308],"salt":[82],"loading":[83],"fludrocortisone":[85],"suppression":[86],"test.":[87],"These":[88],"were":[90,95,122,137,231],"treated":[91,232],"followed-up":[96],"period":[99,128],"up":[101,124],"3":[103],"years.":[104],"RESULTS:":[105],"studied":[107],"28":[108],"(12":[109],"male)":[110],"subjects":[111],"mean":[114,127,140,192],"age":[115],"55":[117],"(s.d.":[118,203],"10)":[119],"years":[120],"followed":[123],"12.9":[130],"(7)":[131],"months.":[132],"At":[133],"baseline,":[134],"taking":[138],"2.1":[142],"(1.2)":[143],"antihypertensive":[144,195,251,287],"drugs,":[145],"but":[146,171,206],"despite":[147],"this":[148,320],"16/28":[149],"(57%)":[150],"had":[151,182,225,293],"diastolic":[152,212,272],"BP":[153,159,265,273],">90":[154],"mmHg,":[155],"39%":[156],"systolic":[158,219],">160":[160],"mmHg.":[161,221],"After":[162],"commencing":[163],"spironolactone,":[164],"three":[165],"complained":[167],"breast":[169],"tenderness":[170],"continued":[172],"treatment":[173,241],"one":[175,207],"patient":[176,208],"was":[177,283,302],"intolerant":[178],"stop":[184],"treatment.":[185],"Of":[186],"remaining":[188],"27":[189],"patients,":[190],"number":[193],"drugs":[196,252],"dropped":[198],"plus":[201],"0.7":[202],"0.9).":[204],"All":[205],"(96%)":[209],"achieved":[210,217],"BP</=90":[213],"mmHg":[214,227,267,277],"78%":[216],"BP</=160":[220],"In":[222],"total":[223],"48%":[224],"BP</=140/90":[226],"13/27":[229],"(48%)":[230],"monotherapy.":[235],"Assessing":[236],"only":[237],"on":[239],"drug":[240],"at":[242],"baseline":[243],"(n=24),":[244],"significantly":[246],"reduced":[247],"need":[249],"by":[253,275],"-0.5":[254],"(CI":[255,268,278],"0.1-1.0),":[256],"P=0.02,":[257],"as":[258,260],"well":[259],"reducing":[261],"[systolic":[264],"-15":[266],"5-25),":[269],"P=0.007":[270],"(mmHg)":[274],"-8":[276],"4-13),":[279],"P=0.001].":[280],"CONCLUSIONS:":[281],"Spironolactone":[282],"highly":[285,303],"effective":[286],"agent":[288],"As":[298],"predictive":[304],"nonsuppression":[306],"suggesting":[310],"aldosteronism,":[312],"might":[314],"worthwhile":[316],"using":[317],"subgroup":[321],"ratios,":[328],"provided":[329],"that":[330],"adrenal":[331],"adenomas":[332],"are":[333],"excluded":[334],"imaging":[336],"techniques.":[337]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2064320461","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":6},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":6}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
